Nuzenio

Targeting Therapy

Targeting Therapy news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Olfactory Receptor Emerges as Therapeutic Target for Resistant Platelet Reactivity in Thrombosis - Cleveland ClinicCleveland Clinic · Fri, 07 Aug 2026 10:50:49 GMT FDA Approves First Orexin-Targeting Therapy for Narcolepsy Type 1 - Medical DialoguesMedical Dialogues · Fri, 07 Aug 2026 02:30:09 GMT Targeting MDA-9 restrains head and neck tumor growth and eliminates therapy resistance - Medical XpressMedical Xpress · Thu, 06 Aug 2026 11:20:01 GMT Intracranial delivery of B7-H3-targeting CAR-T cells for recurrent glioblastoma: a phase 1 trial - NatureNature · Thu, 06 Aug 2026 09:06:55 GMT Targeted myeloma treatment shows promise in Phase 1 trial - Rare Cancer NewsRare Cancer News · Thu, 06 Aug 2026 07:00:00 GMT Nerve-blocking therapy improves growth plate repair in injured bones - News-MedicalNews-Medical · Thu, 06 Aug 2026 03:02:00 GMT Targeting lactylation could overcome cancer therapy resistance challenges - News-MedicalNews-Medical · Thu, 06 Aug 2026 02:04:00 GMT Phase I Trial Evaluates Allogeneic CD70-Targeted CAR T-Cell Therapy in Advanced Renal Cell Carcinoma - The ASCO PostThe ASCO Post · Wed, 05 Aug 2026 14:32:11 GMT

Timeline

Fri, 07 Aug 2026 10:50:49 GMTOlfactory Receptor Emerges as Therapeutic Target for Resistant Platelet Reactivity in Thrombosis - Cleveland Clinic

Fri, 07 Aug 2026 02:30:09 GMTFDA Approves First Orexin-Targeting Therapy for Narcolepsy Type 1 - Medical Dialogues

Thu, 06 Aug 2026 11:20:01 GMTTargeting MDA-9 restrains head and neck tumor growth and eliminates therapy resistance - Medical Xpress

Thu, 06 Aug 2026 09:06:55 GMTIntracranial delivery of B7-H3-targeting CAR-T cells for recurrent glioblastoma: a phase 1 trial - Nature

Thu, 06 Aug 2026 07:00:00 GMTTargeted myeloma treatment shows promise in Phase 1 trial - Rare Cancer News

Thu, 06 Aug 2026 03:02:00 GMTNerve-blocking therapy improves growth plate repair in injured bones - News-Medical

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Rare Cancer News3 live mentions Therapeutic Target2 live mentions Resistant Platelet Reactivity2 live mentions Narcolepsy Type2 live mentions CAR2 live mentions Targeted2 live mentions Phase2 live mentions Medical News2 live mentions Medical2 live mentions Phase I Trial2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Targeting Therapy.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.